Regulation of hepatic ABCC transporters by xenobiotics and in disease states

The subfamily of ABCC transporters consists of 13 members in mammals, including the multidrug resistance-associated proteins (MRPs), sulfonylurea receptors (SURs), and the cystic fibrosis transmembrane conductance regulator (CFTR). These proteins play roles in chemical detoxification, disposition, and normal cell physiology. ABCC transporters are expressed differentially in the liver and are regulated at the transcription and translation level. Their expression and function are also controlled by post-translational modification and membrane-trafficking events. These processes are tightly regulated. Information about alterations in the expression of hepatobiliary ABCC transporters could provide important insights into the pathogenesis of diseases and disposition of xenobiotics. In this review, we describe the regulation of hepatic ABCC transporters in humans and rodents by a variety of xenobiotics, under disease states and in genetically modified animal models deficient in transcription factors, transporters, and cell-signaling molecules.

[1]  Q. Wang,et al.  Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. , 1998, Cancer research.

[2]  M. Piquette-Miller,et al.  Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. , 2000, Molecular cell biology research communications : MCBRC.

[3]  A. Harris,et al.  The CFTR gene and regulation of its expression , 2005, Pediatric pulmonology.

[4]  Y. Iwamoto,et al.  Interleukin‐1β represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells , 2004, Hepatology.

[5]  K. Zatloukal,et al.  Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress , 2007, Drug Metabolism and Disposition.

[6]  P. Jansen,et al.  Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats , 2018 .

[7]  Y. Sugiyama,et al.  Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. , 1998, Molecular pharmacology.

[8]  N. Bradbury,et al.  Endocytic trafficking of CFTR in health and disease. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  K. Hirata,et al.  Functional expression of organic anion transporters in hepatic organoids reconstructed by rat small hepatocytes , 2008, Journal of cellular biochemistry.

[10]  K. Zatloukal,et al.  Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.

[11]  Kuniharu Nakai,et al.  Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model , 2001, Digestive Diseases and Sciences.

[12]  Z. Yao,et al.  Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. , 2008, Cancer letters.

[13]  C. Klaassen,et al.  Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  G. Scheffer,et al.  Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  C. Klaassen,et al.  ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  R. Mancinelli,et al.  Morphological and Functional Heterogeneity of the Mouse Intrahepatic Biliary Epithelium , 2008, Laboratory Investigation.

[17]  M. Dean,et al.  Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. , 2004, Genomics.

[18]  Jatinder Lamba,et al.  Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450* , 2001, The Journal of Biological Chemistry.

[19]  D. Roden,et al.  Human MRP3 transporter: identification of the 5'-flanking region, genomic organization and alternative splice variants. , 1999, Biochimica et biophysica acta.

[20]  D. Besselsen,et al.  Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  D. Mangelsdorf,et al.  Interleukin-1β Suppresses Retinoid Transactivation of Two Hepatic Transporter Genes Involved in Bile Formation* , 2000, The Journal of Biological Chemistry.

[22]  R. Semba,et al.  Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[23]  I. Hyodo,et al.  Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[24]  Y. Sugiyama,et al.  Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. , 1999, Biochemical and biophysical research communications.

[25]  C. Klaassen,et al.  Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. , 2008, Toxicology and applied pharmacology.

[26]  S. Oparil,et al.  Role of oxygen availability in CFTR expression and function. , 2008, American journal of respiratory cell and molecular biology.

[27]  N. LaRusso,et al.  Cholangiocyte bile salt transporters in cholesterol gallstone–susceptible and resistant inbred mouse strains , 2008, Journal of gastroenterology and hepatology.

[28]  J. Uitto,et al.  Tissue-specific expression of the ABCC6 gene. , 2005, The Journal of investigative dermatology.

[29]  X. Chu,et al.  Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) , 2006, Journal of Pharmacology and Experimental Therapeutics.

[30]  K. Sugimachi,et al.  Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. , 2001, Journal of hepatology.

[31]  A. Tordai,et al.  Identification of a DNA Methylation-dependent Activator Sequence in the Pseudoxanthoma Elasticum Gene, ABCC6* , 2005, Journal of Biological Chemistry.

[32]  S. Kitanaka,et al.  Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1β and HNF-1α and the abnormality of HNF-1β mutants , 2007 .

[33]  V. Catania,et al.  ETHYNYLESTRADIOL INCREASES EXPRESSION AND ACTIVITY OF RAT LIVER MRP3 , 2006, Drug Metabolism and Disposition.

[34]  P. Meier,et al.  Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes , 2001, Hepatology.

[35]  P. Borst,et al.  Multidrug resistance-associated proteins 3, 4, and 5 , 2007, Pflügers Archiv - European Journal of Physiology.

[36]  Jingde Zhu,et al.  Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[37]  D. Schrenk,et al.  Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites. , 2001, Toxicology.

[38]  F. Chou,et al.  Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract , 2006, Archives of Toxicology.

[39]  D. Keppler,et al.  The apical conjugate efflux pump ABCC2 (MRP2) , 2007, Pflügers Archiv - European Journal of Physiology.

[40]  Y. Iwamoto,et al.  Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes , 2001, The Journal of Biological Chemistry.

[41]  A. Ikari,et al.  Expression of Hepatic UDP-Glucuronosyltransferase 1A1 and 1A6 Correlated with Increased Expression of the Nuclear Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor α in Male Rats Fed a High-Fat and High-Sucrose Diets⃞ , 2008, Drug Metabolism and Disposition.

[42]  Rosalinde Masereeuw,et al.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.

[43]  Masaki Kobayashi,et al.  Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion. , 2008, Life sciences.

[44]  K. Zatloukal,et al.  Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. , 2003, Journal of hepatology.

[45]  Y. Sugiyama,et al.  Characterization of inducible nature of MRP3 in rat liver. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[46]  F. Lammert,et al.  Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. , 2002, Journal of hepatology.

[47]  Q. Zhu,et al.  Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. , 1994, Cancer research.

[48]  Gerd A. Kullak-Ublick,et al.  Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[49]  D. Schrenk,et al.  Up-regulation of transporters of the MRP family by drugs and toxins. , 2001, Toxicology letters.

[50]  C. Klaassen,et al.  Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. , 2009, Toxicology and applied pharmacology.

[51]  H. Friess,et al.  Gender‐specific expression of liver organic anion transporters in rat , 2005, European journal of clinical investigation.

[52]  O. Fardel,et al.  Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. , 2000, Biochemical pharmacology.

[53]  E. Elias,et al.  Coordinated defence and the liver. , 2007, Clinical medicine.

[54]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[55]  T. Horie,et al.  Oxidative stress and Mrp2 internalization. , 2006, Free radical biology & medicine.

[56]  Ariel D. Quiroga,et al.  Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity , 2007, Archives of Toxicology.

[57]  T. Uchida,et al.  Comparative analysis of ATP‐binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma , 2004, Cancer science.

[58]  A. Gerbes,et al.  Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. , 2005, Journal of hepatology.

[59]  C. Kneuer,et al.  Endogenous expression of liver-specific drug transporters for organic anions in the rat hepatocytoma fusion cell line HPCT-1E3. , 2005, European journal of cell biology.

[60]  Charles Elkan,et al.  The Transporter Classification Database: recent advances , 2008, Nucleic Acids Res..

[61]  K. Chayama,et al.  Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[62]  A. Parkinson,et al.  Regulation of drug transporter gene expression by nuclear receptors. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[63]  K. Brouwer,et al.  Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[64]  C. Gartung,et al.  Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis , 2003, Hepatology.

[65]  J. Boyer,et al.  Cellular localization and up‐regulation of multidrug resistance–associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver , 2001, Hepatology.

[66]  S. Stamm,et al.  Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulator. , 1992, Genomics.

[67]  O. Fardel,et al.  Up‐regulation of multidrug resistance‐associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone , 1999, FEBS letters.

[68]  T. Ishikawa,et al.  MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[69]  K. Zatloukal,et al.  CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice , 2005, Hepatology.

[70]  Y. Kanai,et al.  Posttranslational regulation of Abcc2 expression by SUMOylation system. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[71]  S. Hirano,et al.  Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  C. Sinal,et al.  Vitamin D Receptor-dependent Regulation of Colon Multidrug Resistance-associated Protein 3 Gene Expression by Bile Acids* , 2005, Journal of Biological Chemistry.

[73]  P. Meier,et al.  Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin , 2001, Hepatology.

[74]  O. Le Saux,et al.  [The molecular genetics of pseudoxanthoma elasticum]. , 2001, Annales de dermatologie et de venereologie.

[75]  M. Saier,et al.  The Transporter Classification (TC) System, 2002 , 2002, Critical reviews in biochemistry and molecular biology.

[76]  O. Fardel,et al.  Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells. , 2001, Toxicology.

[77]  Peijin Zhang,et al.  MODULATION OF HEPATIC CANALICULAR OR BASOLATERAL TRANSPORT PROTEINS ALTERS HEPATOBILIARY DISPOSITION OF A MODEL ORGANIC ANION IN THE ISOLATED PERFUSED RAT LIVER , 2005, Drug Metabolism and Disposition.

[78]  H. Seguchi,et al.  Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[79]  J. Marin,et al.  Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3−1 and Can 10 , 2007, Cell and Tissue Research.

[80]  J. Manautou,et al.  Influence of Acetaminophen Vehicle on Regulation of Transporter Gene Expression During Hepatotoxicity , 2007, Journal of toxicology and environmental health. Part A.

[81]  G. Kruh,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .

[82]  J. Manautou,et al.  Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[83]  Y. Lai,et al.  Absolute Difference of Hepatobiliary Transporter Multidrug Resistance-Associated Protein (MRP2/Mrp2) in Liver Tissues and Isolated Hepatocytes from Rat, Dog, Monkey, and Human , 2009, Drug Metabolism and Disposition.

[84]  J. Boyer,et al.  Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. , 2002, Gastroenterology.

[85]  D. Keppler,et al.  Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. , 2003, Journal of hepatology.

[86]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[87]  T. Okada,et al.  Ethanol consumption alters expression and colocalization of bile salt export pump and multidrug resistance protein 2 in the rat , 2007, Histochemistry and Cell Biology.

[88]  J. Marin,et al.  Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. , 2007, Toxicology.

[89]  Y. Sugiyama,et al.  Characterization of 5'-flanking region of human MRP3. , 2000, Biochemical and biophysical research communications.

[90]  M. Wortham,et al.  Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver , 2007, Drug Metabolism and Disposition.

[91]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1 , 1998 .

[92]  S. Kliewer,et al.  Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity* , 2003, Journal of Biological Chemistry.

[93]  Xingguo Cheng,et al.  Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. , 2006, Biochemical pharmacology.

[94]  K. Kohno,et al.  A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.

[95]  A. Hutchinson,et al.  Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. , 2001, Gene.

[96]  D. Häussinger,et al.  Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. , 2000, The Biochemical journal.

[97]  R. Evans,et al.  Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout Mice* , 2004, Journal of Biological Chemistry.

[98]  K. Zatloukal,et al.  Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases , 2001, Hepatology.

[99]  S. Narimatsu,et al.  Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes. , 2008, Biological & pharmaceutical bulletin.

[100]  C. Klaassen,et al.  Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. , 2004, Biochemical and biophysical research communications.

[101]  P. Meier,et al.  Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. , 1999, Gastroenterology.

[102]  M. Vore,et al.  Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition , 2002, Journal of Pharmacology and Experimental Therapeutics.

[103]  R. Béliveau,et al.  Dexamethasone modulation of multidrug transporters in normal tissues , 1999, FEBS letters.

[104]  J. Uitto,et al.  Targeted ablation of Abcc1 or Abcc3 in Abcc6−/− mice does not modify the ectopic mineralization process , 2007, Experimental dermatology.

[105]  D. Häussinger,et al.  Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS , 2004, Biological chemistry.

[106]  J. Boyer,et al.  Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis , 2006, Hepatology.

[107]  J. Marin,et al.  Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. , 2006, Life sciences.

[108]  J. Cohn,et al.  Regulation of membrane chloride currents in rat bile duct epithelial cells. , 1993, The Journal of clinical investigation.

[109]  K. Chayama,et al.  A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion. , 2005, Journal of atherosclerosis and thrombosis.

[110]  R. Béliveau,et al.  Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. , 1999, American journal of physiology. Renal physiology.

[111]  Zhe-Sheng Chen,et al.  ABCC10, ABCC11, and ABCC12 , 2007, Pflügers Archiv - European Journal of Physiology.

[112]  E. Stange,et al.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice. , 2002, The Biochemical journal.

[113]  Rachel J. Johnson,et al.  Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[114]  N. Iizuka,et al.  Methylation of multiple genes as molecular markers for diagnosis of a small, well‐differentiated hepatocellular carcinoma , 2009, International journal of cancer.

[115]  M. Wills Effects of renal failure. , 1990, Clinical biochemistry.

[116]  Olivier Fardel,et al.  Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6 , 2009, Drug Metabolism and Disposition.

[117]  W. V. D. Van de Ven,et al.  The human pseudoxanthoma elasticum gene ABCC6 is transcriptionally regulated by PLAG family transcription factors , 2008, Human Genetics.

[118]  M. Kaito,et al.  Increased hepatic and renal expressions of multidrug resistance‐associated protein 3 in Eisai hyperbilirubinuria rats , 2004, Journal of gastroenterology and hepatology.

[119]  D. Keppler,et al.  Up‐regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver , 2001, Hepatology.

[120]  C. Klaassen,et al.  Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats , 2008, Drug Metabolism and Disposition.

[121]  M. Karin,et al.  Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. , 2007, Drug metabolism and disposition: the biological fate of chemicals.

[122]  T. Ishikawa,et al.  Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. , 2007, Journal of experimental therapeutics & oncology.

[123]  Peijin Zhang,et al.  CHARACTERIZATION OF TRANSPORT PROTEIN EXPRESSION IN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) 2-DEFICIENT RATS , 2006, Drug Metabolism and Disposition.

[124]  William Saurin,et al.  Getting In or Out: Early Segregation Between Importers and Exporters in the Evolution of ATP-Binding Cassette (ABC) Transporters , 1999, Journal of Molecular Evolution.

[125]  D. Schrenk,et al.  Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. , 2001, Toxicology.

[126]  Xingguo Cheng,et al.  TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE , 2005, Drug Metabolism and Disposition.

[127]  J. Ostrow,et al.  Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat. , 2003, Biochemical and biophysical research communications.

[128]  David T Szabo,et al.  Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[129]  D. Häussinger,et al.  Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. , 1999, Gastroenterology.

[130]  J. Boyer,et al.  Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. , 2004, Journal of hepatology.

[131]  D. Keppler,et al.  Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAJ) gene in liver , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[132]  W. Duan,et al.  Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. , 2008, Current medicinal chemistry.

[133]  Y. Sugiyama,et al.  Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices. , 2008, Biological & pharmaceutical bulletin.

[134]  S. Tsuchida,et al.  Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats1 , 2004, Transplantation.

[135]  P. Bosma,et al.  Zonal down‐regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver , 2000, Hepatology.

[136]  Micheline Piquette-Miller,et al.  The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.

[137]  G. F. Sullivan,et al.  Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. , 2000, The Journal of clinical investigation.

[138]  J. Boyer,et al.  HEPATIC AND EXTRAHEPATIC SYNTHESIS AND DISPOSITION OF DINITROPHENYL-S-GLUTATHIONE IN BILE DUCT-LIGATED RATS , 2006, Drug Metabolism and Disposition.

[139]  T. Cantz,et al.  Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B , 1998, Hepatology.

[140]  V. Douet,et al.  DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. , 2007, Biochemical and biophysical research communications.

[141]  C. Carlberg,et al.  The vitamin D receptor. , 2007, Dermatologic clinics.

[142]  Jeffrey S Moffit,et al.  Induction of Hepatic Transporters Multidrug Resistance-Associated Proteins (Mrp) 3 and 4 by Clofibrate Is Regulated by Peroxisome Proliferator-Activated Receptor α , 2006, Journal of Pharmacology and Experimental Therapeutics.

[143]  K. Faber,et al.  ATP binding cassette transporter gene expression in rat liver progenitor cells , 2003, Gut.

[144]  K. Ushinohama,et al.  Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats , 2006, Cancer science.

[145]  D. Keppler,et al.  Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.

[146]  M. Gyamfi,et al.  Mechanisms of Resistance of Hepatocyte Retinoid X Receptor α-Null Mice to WY-14,643-induced Hepatocyte Proliferation and Cholestasis* , 2009, Journal of Biological Chemistry.

[147]  Per Artursson,et al.  Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines , 2007, Drug Metabolism and Disposition.

[148]  D. Miller,et al.  Expression and regulation of the cystic fibrosis gene during rat liver regeneration. , 1992, The American journal of physiology.

[149]  S. Kitanaka,et al.  Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants. , 2007, The Journal of endocrinology.

[150]  L. Ma,et al.  Phosphorylation of the multidrug resistance associated protein gene encoded protein P190. , 1995, Biochemistry.

[151]  T. Hasegawa,et al.  Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. , 2006, Life sciences.

[152]  T. Hasegawa,et al.  Shiga-Like Toxin II Impairs Hepatobiliary Transport of Doxorubicin in Rats by Down-Regulation of Hepatic P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 , 2003, Antimicrobial Agents and Chemotherapy.

[153]  G. Kullak-Ublick,et al.  Hepatocyte Nuclear Factor (HNF) 1 and HNF4 Mediate Hepatic Multidrug Resistance Protein 2 Up-Regulation during Hepatitis C Virus Gene Expression , 2006, Molecular Pharmacology.

[154]  A. Amoroso,et al.  Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ RT-PCR. , 2000, Biochemical and biophysical research communications.

[155]  M. Lieberman,et al.  Altered Gene Expression in the Liver of γ‐Glutamyl Transpeptidase–Deficient Mice , 2000, Hepatology.

[156]  M. Fromm,et al.  Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver , 2003, Journal of Pharmacology and Experimental Therapeutics.

[157]  M. Buchwald,et al.  Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. , 1993, Human molecular genetics.

[158]  Mei-Hwei Chang,et al.  Developmental expression of canalicular transporter genes in human liver. , 2004, Journal of hepatology.

[159]  I. Pastan,et al.  MRP8, A New Member of ABC Transporter Superfamily, Identified by EST Database Mining and Gene Prediction Program, Is Highly Expressed in Breast Cancer , 2001, Molecular medicine.

[160]  J. Wijnholds,et al.  MRP6 (ABCC6) Detection in Normal Human Tissues and Tumors , 2002, Laboratory Investigation.

[161]  Thomas J. Raub,et al.  ALTERED HEPATOBILIARY DISPOSITION OF 5 (AND 6)-CARBOXY-2′,7′-DICHLOROFLUORESCEIN IN Abcg2 (Bcrp1) AND Abcc2 (Mrp2) KNOCKOUT MICE , 2006, Drug Metabolism and Disposition.

[162]  M. Beaussier,et al.  Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[163]  Masashi Kobayashi,et al.  Doxorubicin induces expression of multidrug resistance‐associated protein 1 in human small cell lung cancer cell lines by the c‐jun N‐terminal kinase pathway , 2005, International journal of cancer.

[164]  P. Olinga,et al.  Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[165]  S. Ikushiro,et al.  Beneficial Effect of Spironolactone Administration on Ethynylestradiol-Induced Cholestasis in the Rat: Involvement of Up-Regulation of Multidrug Resistance-Associated Protein 2 , 2007, Drug Metabolism and Disposition.

[166]  H. Glaeser,et al.  Variability in human hepatic MRP4 expression: influence of cholestasis and genotype , 2008, The Pharmacogenomics Journal.

[167]  Thierry Lavé,et al.  Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. , 2002, Biochemical pharmacology.

[168]  Y. Shitara,et al.  Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury. , 2007, Biological & pharmaceutical bulletin.

[169]  G. Hooiveld,et al.  Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. , 1999, Journal of cell science.

[170]  F. Simon,et al.  Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2). , 2009, Toxicology and applied pharmacology.

[171]  Houjie Liang,et al.  Association of Pregnane X Receptor with Multidrug Resistance-Related Protein 3 and its Role in Human Colon Cancer Chemoresistance , 2009, Journal of Gastrointestinal Surgery.

[172]  M. Inoue,et al.  Down-Regulation of a Hepatic Transporter Multidrug Resistance-Associated Protein 2 Is Involved in Alteration of Pharmacokinetics of Glycyrrhizin and Its Metabolites in a Rat Model of Chronic Liver Injury , 2008, Drug Metabolism and Disposition.

[173]  S. Dymarkowski,et al.  Expression of multidrug resistance‐associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[174]  H. Hartmannová,et al.  Rotor‐type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[175]  T. Roskams,et al.  Up‐regulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: A study in patients and in vitro , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[176]  N. Hagenbuch,et al.  Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. , 2001, Journal of hepatology.

[177]  C. Klaassen,et al.  Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. , 2007, Biochimica et biophysica acta.

[178]  K. Zatloukal,et al.  Hepatobiliary transporter expression in human hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[179]  A. Kong,et al.  In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice , 2006, Archives of pharmacal research.

[180]  Kei-ichi Minami,et al.  Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. , 2007, Biochemical pharmacology.

[181]  J. Riordan,et al.  Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. , 1992, European journal of biochemistry.

[182]  Olivier Fardel,et al.  Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[183]  S. Kojima,et al.  Oligonucleotide Microarray Analysis of , 2008 .

[184]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[185]  Wen-Chang Chang,et al.  Transcriptional regulation of the rat Mrp3 gene promoter by the specificity protein (Sp) family members and CCAAT/enhancer binding proteins. , 2005, Journal of biomedical science.

[186]  K. Miyamoto,et al.  Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride , 2007, Biopharmaceutics & drug disposition.

[187]  I. Arias,et al.  Intracellular Trafficking and Regulation of Canalicular ATP-Binding Cassette Transporters , 2000, Seminars in liver disease.

[188]  Mi-Sook Kim,et al.  Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[189]  M. Nishimura,et al.  Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and down-regulation induced by overdose of fat-free total parenteral nutrition in infant rats. , 2005, Drug metabolism and pharmacokinetics.

[190]  D. Keppler,et al.  Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes , 2002, Nature Genetics.

[191]  G. Friedlander,et al.  Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. , 2001, American journal of physiology. Renal physiology.

[192]  M. Iwaki,et al.  Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat. , 2009, Biopharmaceutics & drug disposition.

[193]  O. Fardel,et al.  Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. , 2002, Biochemical pharmacology.

[194]  J. Petrick,et al.  Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport , 2007, Drug Metabolism and Disposition.

[195]  M. Honda,et al.  Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma. , 2008, Journal of hepatology.

[196]  J. Bryan,et al.  ABCC8 and ABCC9: ABC transporters that regulate K+ channels , 2007, Pflügers Archiv - European Journal of Physiology.

[197]  D. Keppler,et al.  Induction of cMrp/cMoat gene expression by cisplatin, 2‐ acetylaminofluorene, or cycloheximide in rat hepatocytes , 1997, Hepatology.

[198]  Y. Sugiyama,et al.  Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. , 2008, Biological & pharmaceutical bulletin.

[199]  J. Boyer,et al.  Tumor Necrosis Factor (cid:1) -dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis* , 2022 .

[200]  H. Takikawa,et al.  Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury , 2004, Journal of Gastroenterology.

[201]  Xingguo Cheng,et al.  Regulation of mRNA Expression of Xenobiotic Transporters by the Pregnane X Receptor in Mouse Liver, Kidney, and Intestine , 2006, Drug Metabolism and Disposition.

[202]  N. Ballatori,et al.  Intracellular glutathione regulates taurocholate transport in HepG2 cells. , 2001, Toxicology and applied pharmacology.

[203]  Masaki Kobayashi,et al.  Characterization of hepatobiliary organic anion transporters in Long-Evans Cinnamon rats. , 2007, Drug metabolism and pharmacokinetics.

[204]  S. Cole,et al.  Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions. , 2003, Molecular pharmacology.

[205]  M. Kaito,et al.  Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn rats. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[206]  Ulrich Hoffmann,et al.  Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition , 2006, Expert opinion on drug metabolism & toxicology.

[207]  S. Teng,et al.  Induction of ABCC3 (MRP3) by pregnane X receptor activators. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[208]  M. Karin,et al.  Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis , 2007, Drug Metabolism and Disposition.

[209]  K. Zatloukal,et al.  Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[210]  V. Vollrath,et al.  Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. , 1999, The Biochemical journal.

[211]  J. Marin,et al.  Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis. , 2005, Clinical science.

[212]  S. Teng,et al.  Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis , 2007, British journal of pharmacology.

[213]  N. Van Rooijen,et al.  Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function. , 2009, Toxicology and applied pharmacology.

[214]  K. Kohno,et al.  Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. , 1998, Biochemical and biophysical research communications.

[215]  G. Decorti,et al.  Physiological regulation of P‐glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny , 2003, Development, growth & differentiation.

[216]  J. Idle,et al.  Role of Pregnane X Receptor in Control of All-Trans Retinoic Acid (ATRA) Metabolism and Its Potential Contribution to ATRA Resistance , 2008, Journal of Pharmacology and Experimental Therapeutics.

[217]  J. Boyer,et al.  Nuclear receptors RXRα:RARα are repressors for human MRP3 expression , 2007 .

[218]  P. Novikoff,et al.  MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[219]  C. Paulusma,et al.  Activity of the Bile Salt Export Pump (ABCB11) Is Critically Dependent on Canalicular Membrane Cholesterol Content , 2009, Journal of Biological Chemistry.

[220]  T. Kamisako,et al.  Alteration of the expression of adenosine triphosphate‐binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis , 2005, Journal of gastroenterology and hepatology.

[221]  F. Lammert,et al.  Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. , 2001, Gastroenterology.

[222]  E. Elovic,et al.  St. John's Wort , 2001, The Journal of head trauma rehabilitation.

[223]  Y. Sugiyama,et al.  Expression and regulation of breast cancer resistance protein and multidrug resistance associated protein 2 in BALB/c mice. , 2006, Biological & pharmaceutical bulletin.

[224]  E. Denamur,et al.  Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. , 1997, The Biochemical journal.

[225]  M. Perassolo,et al.  Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. , 2004, Biochemical pharmacology.

[226]  D. Rurak,et al.  Stereoselective pharmacokinetics of fluoxetine and norfluoxetine enantiomers in pregnant sheep. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[227]  P. Annaert,et al.  The ontogeny of drug metabolizing enzymes and transporters in the rat. , 2008, Reproductive toxicology.

[228]  M. Iwaki,et al.  Decreased PXR and CAR inhibit transporter and CYP mRNA Levels in the liver and intestine of mice with collagen-induced arthritis , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[229]  U. Beuers,et al.  Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. , 2001, Liver.

[230]  D. Keppler,et al.  Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma , 2001, International journal of cancer.

[231]  I. Pastan,et al.  Decreased accumulation of [14c]carboplatin in human cisplatin‐resistant cells results from reduced energy‐dependent uptake , 2000, Journal of cellular physiology.

[232]  H. Takano,et al.  The human multidrug resistance protein 2 gene: Functional characterization of the 5′‐flanking region and expression in hepatic cells , 1999, Hepatology.

[233]  C. Gartung,et al.  Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. , 2003, Biochemical and biophysical research communications.

[234]  D. Besselsen,et al.  Efflux Transporter Expression and Acetaminophen Metabolite Excretion Are Altered in Rodent Models of Nonalcoholic Fatty Liver Disease , 2007, Drug Metabolism and Disposition.

[235]  K. Zatloukal,et al.  A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. , 2007, The American journal of pathology.

[236]  V. Barbu,et al.  Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation , 2006, Hepatology.

[237]  G. Bartosz,et al.  Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. , 2006, Biochemical and biophysical research communications.

[238]  Sharmilee P. Sawant,et al.  Renal and hepatic transporter expression in type 2 diabetic rats. , 2008, Drug metabolism letters.

[239]  Peijin Zhang,et al.  Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[240]  C. Klaassen,et al.  Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[241]  E. Jeffery,et al.  Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines. , 2008, The Journal of nutritional biochemistry.

[242]  B. Strandvik,et al.  Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis , 2000, Hepatology.

[243]  T. Kume,et al.  Decreased hepatobiliary transport of methotrexate in adjuvant arthritis rats , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[244]  J. Peters,et al.  Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[245]  A. Plomp,et al.  ABCC6 and pseudoxanthoma elasticum , 2007, Pflügers Archiv - European Journal of Physiology.

[246]  K. Yamada,et al.  St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[247]  S. Teng,et al.  THE ROLE OF PREGNANE X RECEPTOR IN 2-ACETYLAMINOFLUORENE-MEDIATED INDUCTION OF DRUG TRANSPORT AND -METABOLIZING ENZYMES IN MICE , 2006, Drug Metabolism and Disposition.

[248]  N. Itoh,et al.  Effects of genetic backgrounds on hyperbilirubinemia in radixin-deficient mice due to different expression levels of Mrp3. , 2007, Biochimica et biophysica acta.

[249]  E. Neufeld,et al.  Transcriptional Repression of the Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mediated by CCAAT Displacement Protein/cut Homolog, Is Associated with Histone Deacetylation* , 1999, The Journal of Biological Chemistry.

[250]  Y. Sugiyama,et al.  The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function , 2001, American Journal of Gastroenterology.

[251]  Peijin Zhang,et al.  Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. , 2003, Molecular pharmacology.

[252]  C. Manohar,et al.  MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma , 2004, Oncogene.

[253]  Katsuya Kobayashi,et al.  Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol or dexmedetomidine anesthesia. , 2009, Biomedical research.

[254]  T. Roskams,et al.  Expression and regulation of ABC transporter genes during liver regeneration , 2018 .

[255]  I. Arias,et al.  Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[256]  P. Borst,et al.  MRP2 and 3 in health and disease. , 2006, Cancer letters.

[257]  Jianzhu Chen,et al.  Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. , 2008, Biochimica et biophysica acta.

[258]  P. Neuvonen,et al.  Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics , 2006, Pharmacogenetics and genomics.

[259]  J. Miquel,et al.  Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function , 2004, Gut.

[260]  J. Uitto,et al.  Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. , 2006, The Journal of investigative dermatology.

[261]  F. Suchy,et al.  Differential Developmental Regulation of Rat Liver Canalicular Membrane Transporters Bsep and Mrp2 , 2003, Pediatric Research.

[262]  M. Nagino,et al.  Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[263]  K. Faber,et al.  LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[264]  L. Homolya,et al.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) , 2007, Pflügers Archiv - European Journal of Physiology.

[265]  M. Kool,et al.  Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.

[266]  D. Moore,et al.  Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[267]  D. Keppler,et al.  Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen , 1998, Archives of Toxicology.

[268]  R. Ashfield,et al.  Cloning of the Promoters for the β-Cell ATP-Sensitive K-Channel Subunits Kir6.2 and SUR1 , 1998, Diabetes.

[269]  P. Meier,et al.  Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[270]  D. Häussinger,et al.  Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. , 1999, The Biochemical journal.

[271]  C. Klaassen,et al.  Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. , 2006, Life sciences.

[272]  T. Kawaguchi,et al.  Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis , 2000, Hepatology.

[273]  Daisaku Hachimine,et al.  The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. , 2007, International journal of oncology.

[274]  M. Piquette-Miller,et al.  Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. , 2001, Canadian journal of physiology and pharmacology.

[275]  H. Denk,et al.  Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[276]  Q. Zhu,et al.  Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. , 1996, DNA and cell biology.

[277]  M. Müller,et al.  Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. , 1997, Gastroenterology.

[278]  D. Bell,et al.  Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. , 1998, Cancer research.

[279]  Wen Xie,et al.  Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. , 2006, The Journal of biological chemistry.

[280]  G. Scheffer,et al.  Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. , 2008, Molecular pharmaceutics.

[281]  S. Cole,et al.  Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. , 2001, Biochemical and biophysical research communications.

[282]  J. Osterreicher,et al.  Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. , 2005, Physiological research.

[283]  Curtis D. Klaassen,et al.  INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER , 2005, Drug Metabolism and Disposition.

[284]  F. Di Virgilio,et al.  Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. , 2001, Gastroenterology.

[285]  F. Gonzalez,et al.  Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity* , 2003, The Journal of Biological Chemistry.

[286]  Mi-Sook Kim,et al.  Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[287]  F. Lammert,et al.  Interleukin-6 regulates hepatic transporters during acute-phase response. , 2004, Biochemical and biophysical research communications.

[288]  Michel Eichelbaum,et al.  Interindividual variability of canalicular ATP‐binding‐cassette (ABC)–transporter expression in human liver , 2006, Hepatology.

[289]  G. Scheffer,et al.  Induction of Hepatobiliary Efflux Transporters in Acetaminophen-Induced Acute Liver Failure Cases , 2007, Drug Metabolism and Disposition.

[290]  F. Lammert,et al.  Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. , 2002, Journal of hepatology.

[291]  G. Yen,et al.  Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. , 2006, The Journal of nutrition.

[292]  P. Meier,et al.  Differential expression of bile salt and organic anion transporters in developing rat liver. , 2004, Journal of hepatology.

[293]  M. Vore,et al.  Translational Regulation of Rat Multidrug Resistance-Associated Protein 2 Expression Is Mediated by Upstream Open Reading Frames in the 5′ Untranslated Region , 2007, Molecular Pharmacology.

[294]  D. Häussinger,et al.  Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[295]  Lorella Pascolo,et al.  Gene Expression of ABC Proteins in Hepatocellular Carcinoma, Perineoplastic Tissue, and Liver Diseases , 2002, Molecular medicine.

[296]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.

[297]  T. Ishikawa,et al.  Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. , 2001, Biochemical and biophysical research communications.

[298]  Andrei A. Aleksandrov,et al.  CFTR (ABCC7) is a hydrolyzable-ligand-gated channel , 2007, Pflügers Archiv - European Journal of Physiology.

[299]  P. Meier,et al.  Small hepatocytes in culture develop polarized transporter expression and differentiation , 2004, Journal of Cell Science.

[300]  J. Boyer,et al.  Organ-specific alterations in RARα:RXRα abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis , 2002 .

[301]  A. Slitt,et al.  Induction of drug metabolism enzymes and transporters by oltipraz in rats , 2008, Journal of biochemical and molecular toxicology.

[302]  J. Osterreicher,et al.  Zonation of multidrug resistance‐associated protein 2 in rat liver after induction with dexamethasone , 2008, Journal of gastroenterology and hepatology.

[303]  Ning Li,et al.  Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[304]  N. Ballatori,et al.  Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[305]  D. Schrenk,et al.  Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. , 1998, Biochemical and biophysical research communications.

[306]  C. Deutschman,et al.  Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. , 2000, Shock.

[307]  J. Boyer,et al.  ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. , 2009, Gastroenterology.

[308]  Hong Sun,et al.  Effects of renal failure on drug transport and metabolism. , 2006, Pharmacology & therapeutics.

[309]  Paul T Tarr,et al.  Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.

[310]  A. Unami,et al.  Possible involvement of oxidative stress in piperonyl butoxide induced hepatocarcinogenesis in rats. , 2007, Toxicology.

[311]  F. Burczynski,et al.  Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation , 2005, Journal of cellular physiology.

[312]  O. Fardel,et al.  Down-Regulation of Organic Anion Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokine Interleukin , 2008 .

[313]  M. Ho,et al.  Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary Atresia , 2008, Pediatric Research.

[314]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[315]  Balázs Sarkadi,et al.  The role of multidrug transporters in drug availability, metabolism and toxicity. , 2003, Toxicology letters.

[316]  L. Pulaski,et al.  Liver-specific enhancer in ABCC6 promoter-Functional evidence from natural polymorphisms. , 2009, Biochemical and biophysical research communications.

[317]  J. Capeau,et al.  Role for PKC α and PKC ε in down-regulation of CFTR mRNA in a human epithelial liver cell line , 1998 .

[318]  N. Tepsiri,et al.  Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. , 2005, World journal of gastroenterology.

[319]  K. Kuča,et al.  The influence of acetylcholinesterase reactivators on selected hepatic functions in rats. , 2008, Basic & clinical pharmacology & toxicology.

[320]  B. Zhang,et al.  Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. , 2005, Journal of experimental & clinical cancer research : CR.

[321]  V. Vollrath,et al.  Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. , 2006, The Biochemical journal.

[322]  V. Catania,et al.  Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats , 2008, Drug Metabolism and Disposition.

[323]  K. Mitsumori,et al.  Threshold dose of piperonyl butoxide that induces reactive oxygen species-mediated hepatocarcinogenesis in rats , 2009, Archives of Toxicology.

[324]  Shufeng Zhou,et al.  Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. , 2007, Current drug metabolism.

[325]  D. Häussinger,et al.  Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. , 2003, Archives of biochemistry and biophysics.

[326]  C. Klaassen,et al.  Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[327]  Y. Sugiyama,et al.  cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). , 1998, FEBS letters.

[328]  G. Hooiveld,et al.  Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .

[329]  K. Zatloukal,et al.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.

[330]  Michael Dean,et al.  Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. , 2005, Annual review of genomics and human genetics.

[331]  T. Guo,et al.  Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. , 2009, Archives of biochemistry and biophysics.

[332]  K. Kubo,et al.  Induction of Multidrug Resistance-Associated Protein MRP3 in the Liver of Rats Fed with Docosahexaenoic Acid , 2006, Bioscience, biotechnology, and biochemistry.

[333]  Balázs Sarkadi,et al.  The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). , 2008, Drug discovery today.

[334]  Masayuki Yamamoto,et al.  Oxidative and electrophilic stress induces multidrug resistance–associated protein transporters via the nuclear factor‐E2–related factor‐2 transcriptional pathway , 2007, Hepatology.

[335]  F. Lammert,et al.  Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[336]  M. Eichelbaum,et al.  Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine , 2006, Clinical pharmacology and therapeutics.

[337]  C. Klaassen,et al.  Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[338]  D. Keppler,et al.  Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. , 2000, European journal of biochemistry.

[339]  Y. Sugiyama,et al.  Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[340]  C. Klaassen,et al.  Expression of rat Multidrug Resistance Protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny. , 2002, Toxicology.

[341]  D. Moore,et al.  trans-Stilbene Oxide Induces Expression of Genes Involved in Metabolism and Transport in Mouse Liver via CAR and Nrf2 Transcription Factors , 2006, Molecular Pharmacology.

[342]  K. Takagi,et al.  Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. , 2008, Biochimica et biophysica acta.

[343]  Yuichi Sugiyama,et al.  Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. , 2003, Biochemical and biophysical research communications.

[344]  T. Nishiya,et al.  Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[345]  F. Matsuda,et al.  Identification of a Novel 974C→G Nonsense Mutation of the MRP2/ABCC2 Gene in a Patient with Dubin-Johnson Syndrome and Analysis of the Effects of Rifampicin and Ursodeoxycholic Acid on Serum Bilirubin and Bile Acids , 2006, The American Journal of Gastroenterology.

[346]  C. Klaassen,et al.  Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[347]  K. Köhrer,et al.  Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[348]  R. Evans,et al.  Benefit of farnesoid X receptor inhibition in obstructive cholestasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[349]  J. Fenyk-Melody,et al.  Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR− rats , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[350]  P. D. de Jong,et al.  Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. , 2003, Survey of ophthalmology.

[351]  C. Klaassen,et al.  Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[352]  K. Brouwer,et al.  P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide , 2004, Pharmaceutical Research.

[353]  M. Kool,et al.  Tissue Distribution and Induction of Human Multidrug Resistant Protein 3 , 2002, Laboratory Investigation.

[354]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[355]  K. Chayama,et al.  Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. , 2001, The Biochemical journal.

[356]  F. Leblond,et al.  Effects of Chronic Renal Failure on Liver Drug Transporters , 2008, Drug Metabolism and Disposition.

[357]  C. Klaassen,et al.  Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[358]  M. Vore,et al.  The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2) , 2005, Molecular Pharmacology.

[359]  D. Keppler,et al.  The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. , 1997, Gastroenterology.

[360]  A. Guillouzo,et al.  Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. , 2009, Toxicology and applied pharmacology.

[361]  S. Sahlin,et al.  Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. , 2005, Gastroenterology.

[362]  D. Keppler,et al.  Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane , 2003, Hepatology.

[363]  K. Faber,et al.  Multidrug resistance–associated proteins are crucial for the viability of activated rat hepatic stellate cells , 2008, Hepatology.

[364]  D. Rees,et al.  ABC transporters: the power to change , 2009, Nature Reviews Molecular Cell Biology.

[365]  K. Zatloukal,et al.  Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. , 2003, Journal of hepatology.

[366]  M. L. Alvarez,et al.  Biliary secretory function in rats chronically intoxicated with aluminum. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[367]  M. Negishi,et al.  INDUCTION OF GENES FOR METABOLISM AND TRANSPORT BY TRANS-STILBENE OXIDE IN LIVERS OF SPRAGUE-DAWLEY AND WISTAR-KYOTO RATS , 2006, Drug Metabolism and Disposition.

[368]  M. Piquette-Miller,et al.  Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia , 2002, Journal of Pharmacology and Experimental Therapeutics.

[369]  M. Kool,et al.  Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.

[370]  M. Fromm,et al.  Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. , 2004, Pharmacogenetics.

[371]  V. Ling,et al.  Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.

[372]  V. Douet,et al.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. , 2006, Biochimica et biophysica acta.

[373]  D. Keppler,et al.  Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis , 2005, Hepatology.

[374]  K. Brouwer,et al.  Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity. , 2008, Toxicology and applied pharmacology.

[375]  T. Hasegawa,et al.  Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. , 2005, European journal of pharmacology.

[376]  K. Pang,et al.  Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[377]  Y. Sugiyama,et al.  Genipin enhances Mrp2 (Abcc2)‐mediated bile formation and organic anion transport in rat liver , 2004, Hepatology.

[378]  H. Aburatani,et al.  ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. , 2002, Biochemical and biophysical research communications.

[379]  C. Garrovo,et al.  St John's wort modulation and developmental expression of multidrug transporters in the rat , 2006, Phytotherapy research : PTR.

[380]  T. Horie,et al.  Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status. , 2008, American journal of physiology. Gastrointestinal and liver physiology.